"It is estimated there are 5,000 to 10,000 EPP patients worldwide"
At ~$130K per patient that would be a $650M-$1.3B opportunity, per annum.
But just keep popping in every few hours to tell us that it's only 3,000 - perhaps it will make you feel less bitter with other people's success?
News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment, page-55
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.95 |
Change
0.360(2.47%) |
Mkt cap ! $748.6M | |||
| Open | High | Low | Value | Volume |
| $14.76 | $14.96 | $14.46 | $1.416M | 95.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 203 | $14.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.96 | 4532 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |